Company news

Arecor Therapeutics PLC news in 2023

Arecor Therapeutics PLC's news releases, calls and decks from 2023, newest first.

View company

Agreement with global medical products company

December 4, 2023

Arecor Continues Collaboration with Lilly

November 29, 2023

Product with Arestat technology launched in Europe

November 17, 2023

Inhibrx milestone triggers payment to Arecor

November 2, 2023

Exercise of rollover options & Total Voting Rights

November 1, 2023

Progress of Phase I clinical study of AT278

October 2, 2023

Arecor on Investor Meet Company Platform

September 15, 2023

Interim Results for six months ended 30 June 2023

September 14, 2023

Arecor: positive Hikma FDA pre-IND meeting

September 7, 2023

Tetris pharma announces agreement with Goodlife

September 4, 2023

Collaboration With Top 10 Global Pharma

August 17, 2023

Arecor Business Update

July 20, 2023

Additional Agreement with Leading Biopharma

July 5, 2023

Arecor granted key patents in Europe and China

June 27, 2023

Arecor presents positive data for AT247 at ADA

June 26, 2023

AGM Statement

June 9, 2023

Director/PDMR Shareholding

May 24, 2023

Tetris pharma launches Ogluo® in Denmark & Norway

May 15, 2023

Arecor 2022 annual report and notice of AGM

May 4, 2023

Arecor Granted Key U.S Patent

April 26, 2023

Unaudited Preliminary Results for 2022

April 20, 2023

Arecor Appoints Chief Business Officer

April 5, 2023

First patient dosed in AT278 clinical trial

March 22, 2023

Price Monitoring Extension

March 13, 2023

Second Price Monitoring Extn

March 13, 2023

Arecor to present sharesoc webinar

March 1, 2023

Arecor Granted Patents in India and the US

February 16, 2023

Arecor strengthens collaboration with partner

February 14, 2023

Arecor Publishes Data for AT278 in Diabetes Care

January 30, 2023

Business update

January 19, 2023

Arecor announces transfer of AT307 to Hikma

January 12, 2023

Tetris pharma launches Ogluo® in Austria

January 4, 2023

Calls in 2023

Decks in 2023